Cordis Wins FDA Approval for SELUTION SLR Balloon
Miami Lakes, Florida, U.S., September 21, 2026 Cordis has announced that the U.S. Food and Drug Administration (FDA) has...
cardiovascular technology
Advertisement
Johnson & Johnson Wins FDA Approval for Dual Energy Platform
IRVINE, Calif., July 8, 2026 Johnson & Johnson MedTech has announced that the U.S. Food and Drug Administration (FDA)...
REGENXBIO Advances NAVSUNLI Toward Accelerated Approval
ROCKVILLE, Maryland, June 22, 2026 REGENXBIO has announced a significant regulatory milestone for NAVSUNLI™ (clemidsogene lanparvovec-sngl, RGX-121), its investigational...
AbbVie to Acquire Apogee in $10.9B Immunology Expansion
NORTH CHICAGO, Illinois, and SAN FRANCISCO, California, June 22, 2026 AbbVie has announced a definitive agreement to acquire Apogee...
Murj Expands Cardiac Care Platform Across Australia and NZ
SYDNEY, Australia and AUCKLAND, New Zealand, June 21, 2026 Murj®, a leading provider of cardiac device management software, has...
Advertisements
VahatiCor Enrolls First U.S. Patient in A-FLUX SERRA-I Trial
SANTA CLARA, Calif., June 17, 2026 VahatiCor, Inc., a medical device company focused on developing innovative therapies for coronary...
Tempus Launches AI Prostate Test for Advanced Cancer
Chicago, Illinois, USA – May 21, 2026 Tempus AI, Inc., a leader in artificial intelligence and precision medicine, announced...
Bayer Gains FDA Priority Review for Kerendia
WHIPPANY, N.J., May 21, 2026 Bayer has announced that the U.S. Food and Drug Administration (FDA) has granted Priority...
Reflow Medical Reports Positive Six-Month Spur Elute Coronary Study Results
SAN CLEMENTE, Calif., May 20, 2026 Reflow Medical, Inc. has announced encouraging six-month clinical results from its DEEPER CORONARY...
Implantica Advances RefluxStop Toward FDA Approval
ZUG, Switzerland, May 20, 2026 Implantica AG announced that it has submitted its final response to the U.S. Food...
Advertisement
